UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brain atrophy in Alzheimer’s Disease and aging

Ageing research reviews, 2016-09, Vol.30, p.25-48

2016

Volltextzugriff (PDF)

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease

Brain (London, England : 1878), 2018-07, Vol.141 (7), p.1917-1933

2018

Volltextzugriff (PDF)

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

Alzheimer's & dementia, 2018-04, Vol.14 (4), p.492-501

2018

Volltextzugriff (PDF)

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease

Scientific reports, 2017-09, Vol.7 (1), p.11706-10, Article 11706

2017

Volltextzugriff (PDF)

Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore

European radiology, 2022-05, Vol.32 (5), p.2949-2961

2022

Volltextzugriff (PDF)

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

Alzheimer's & dementia, 2015-09, Vol.11 (9), p.1041-1049

2015

Volltextzugriff (PDF)

Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects

NeuroImage clinical, 2022-01, Vol.33, p.102940-102940, Article 102940

2022

Volltextzugriff (PDF)

Cortex and amygdala morphology in psychopathy

Psychiatry research. Neuroimaging, 2011-08, Vol.193 (2), p.85-92

2011

Volltextzugriff (PDF)

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment

Alzheimer's research & therapy, 2023-10, Vol.15 (1), p.177-177, Article 177

2023

Volltextzugriff (PDF)

Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study

Aging clinical and experimental research, 2020-05, Vol.32 (5), p.817-826

2020

Volltextzugriff (PDF)

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

Translational psychiatry, 2021-01, Vol.11 (1), p.78-11, Article 78

2021

Volltextzugriff (PDF)

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors

Frontiers in neurology, 2018-08, Vol.9, p.642

2018

Volltextzugriff (PDF)

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

Alzheimer's research & therapy, 2022-09, Vol.14 (1), p.1-131, Article 131

2022

Volltextzugriff (PDF)

Reply: Optimal use of cholinergic drugs in Alzheimer's disease

Brain (London, England : 1878), 2018-09, Vol.141 (9), p.e69-e69

2018

Volltextzugriff (PDF)

Efficacy of lifestyle interventions on clinical and neuroimaging outcomes in elderly

Ageing research reviews, 2016-01, Vol.25, p.1-12

2016

Volltextzugriff (PDF)

Prevalence and clinical associations of atrophy subtypes using clinical routine image analysis software in MCI patients from a memory clinic population

Alzheimer's & dementia, 2023-06, Vol.19 (S3), p.n/a

2023

Volltextzugriff (PDF)

Four‐year cognitive decline in mild cognitive impairment patients with distinct baseline neuroanatomical atrophy profiles: A MEMENTO and QyScore® study

Alzheimer's & dementia, 2023-06, Vol.19 (S4), p.n/a

2023

Volltextzugriff (PDF)

Relationship between MTA visual scale scores and hippocampal volume measured by a medical device in patients from a multicentric memory clinic population

Alzheimer's & dementia, 2023-06, Vol.19 (S3), p.n/a

2023

Volltextzugriff (PDF)

Correlation between quantitative and qualitative assessments of white matter hyperintensities in patients from a multicentric memory clinic population

Alzheimer's & dementia, 2023-06, Vol.19 (S2), p.n/a

2023

Volltextzugriff (PDF)

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

Alzheimer's & dementia, 2019-06, Vol.15 (6), p.764-775

2019

Volltextzugriff (PDF)

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1-42 , total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

Alzheimer's & dementia, 2018-04, Vol.14 (4), p.492-501

2018

Volltextzugriff (PDF)

Correlation between quantitative and qualitative assessments of white matter hyperintensities inpatients from a multicentric memory clinic population

Alzheimer's & dementia, 2022-12, Vol.18 (S1), p.n/a

2022

Volltextzugriff (PDF)

Four‐year cognitive decline in mild cognitive impairment patients with distinct baseline neuroanatomical atrophy profiles: A MEMENTO and QyScore® study

Alzheimer's & dementia, 2022-12, Vol.18 (S1), p.n/a

2022

Volltextzugriff (PDF)

Prevalence and clinical associations of atrophy subtypes using clinical routine image analysis software in MCI patients from a memory clinic population

Alzheimer's & dementia, 2022-12, Vol.18 (S1), p.n/a

2022

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

ThemaBiomarkers

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(160)

Publikationsform

Artikel
(171)

Sprache

Englisch
(171)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brain atrophy in Alzheimer’s Disease and aging

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease

Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects

Cortex and amygdala morphology in psychopathy

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment

Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

Reply: Optimal use of cholinergic drugs in Alzheimer's disease

Efficacy of lifestyle interventions on clinical and neuroimaging outcomes in elderly

Prevalence and clinical associations of atrophy subtypes using clinical routine image analysis software in MCI patients from a memory clinic population

Four‐year cognitive decline in mild cognitive impairment patients with distinct baseline neuroanatomical atrophy profiles: A MEMENTO and QyScore® study

Relationship between MTA visual scale scores and hippocampal volume measured by a medical device in patients from a multicentric memory clinic population

Correlation between quantitative and qualitative assessments of white matter hyperintensities in patients from a multicentric memory clinic population

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1-42 , total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

Correlation between quantitative and qualitative assessments of white matter hyperintensities inpatients from a multicentric memory clinic population

Four‐year cognitive decline in mild cognitive impairment patients with distinct baseline neuroanatomical atrophy profiles: A MEMENTO and QyScore® study

Prevalence and clinical associations of atrophy subtypes using clinical routine image analysis software in MCI patients from a memory clinic population

Aktive Filter

Suchergebnisse filtern